In patients with schizophrenia, extrapyramidal symptoms (EPS) and tardive syndromes are commonly associated with exposure to conventional antipsychotics such as haloperidol and can lead to noncompliance. Atypical antipsychotics are much less likely to cause such side effects and often reduce these problems (1) , though there are differences among drugs within this class (2) . Here I report the history of a patient with schizophrenia who suffered distressing, involuntary contractures of the neck muscles (torticollis).
Case Report
Miss C, aged 35 years, was diagnosed with paranoid schizophrenia at age 24 years, while attending university. She received intramuscular, short-acting haloperidol (1 dose of 10 mg) and developed torticollis. Torticollis persisted for 1 year, despite treatment with a reduced dosage of haloperidol, a dosage of chlorpromazine (maximum 400 mg daily) and several side effect medications (specifically, benztropine, procyclidine, amantadine, and lorazepam). A neurological consultant believed the muscle contractures were secondary to the antipsychotic medication. Following the failure of tetrabenazine (maximum 75 mg daily) to reduce the contractures, the patient and her family refused antipsychotic medication, believing the cure was worse than the illness. Over the next 5 years, Miss C attended the emergency department 18 times, with agitated or aggressive behaviour and was treated with various antipsychotics, with moderate response and little improvement in neck dystonia. Outside of hospital, she refused medication and was largely housebound.
In May 1998, the family brought her to hospital because she had threatened her father with a knife. She was experiencing auditory hallucinations and believed an outside force was controlling her thoughts. She had a marked twisting of the neck, which she found very distressing. Her total score on the Positive and Negative Syndrome Scale (PANSS) was 108 and the neck dystonia was considered severe on the Clinical Global Impression of severity of dystonia scale (the Extrapyramidal Symptom Rating Scale).
A trial of clozapine was undertaken, but despite moderate improvement in neck dystonia, clozapine was discontinued after 4 weeks because of neutropenia. The patient then received an increasing dosage of quetiapine (50 to 800 mg daily over 3 weeks) and demonstrated a moderate initial response. Over 6 weeks, after a dosage of 800 mg daily was achieved, her delusions abated, her agitation ceased, and she stopped responding to auditory hallucinations. The dystonic neck posture normalized, with neck muscle spasms causing only occasional concern. Her PANSS total score was 67, and severity of dystonia was mild.
This case demonstrates that switching to second-generation antipsychotics may improve tardive dystonia. Both clozapine and quetiapine have demonstrated placebo-level EPS across the dosage range (3, 4) . However, clozapine is associated with agranulocytosis and requires regular blood monitoring (5) , which may decrease its acceptability to patients. Further, quetiapine has demonstrated efficacy in patients who have switched from other antipsychotics following an inadequate response or intolerance (6, 7) . In the treatment of schizophrenia appropriate side effect management is important in ensuring that poor compliance, and subsequently poor outcome, are avoided. The patient and her family were very pleased with the resolution of the neck dystonia with quetiapine, and as a result, she continues on her medication, has returned to part-time education, and remains in good health.
Sean W Flynn MD, FRCPC Port Coquitlam, British Columbia

Internalizing Antecedents of Conduct Disorder
Dear Editor:
This letter provides findings about the importance of early internalizing conditions for later externalizing disorders. Several lines of research suggest that behavioural abnormalities may often precede the onset of conduct disorder (CD). However, while there is evidence that attention-deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) precede CD (1), questions remain concerning the association with internalizing conditions. The nature of such a relation is still subject to alternative interpretations. The more consistent hypothesis is that internalizing problems are a reaction to CD, but other studies indicate that the internalizing symptoms predict externalizing problems that occur later.
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